glp-1 receptor agonist antipsychotic weight gain study Impacts of Glucagon-like Peptide-1 Receptor-Agonist (GLP-1 RA) Treatment for Metabolic Disturbances and in Patients on Clozapine/Olanzapine: A Systematic Review Weight Loss Drugs May Also

Also, patients with renal impairment should monitor kidney function when taking these medications

However, 47% of those with diabetes and 36% with obesity who discontinued these medications restarted them again within a year

Abbasinejad, MD , and her team are excited to offer this new oral option as part of our comprehensive Medical Weight Loss & Wellness Program

That's a clear benefit when it comes to outsmarting diabetes

doi:10.3390/medicina59050985 Chandrakumar H, Khatun N, Gupta T, GrahamHill S, Zhyvotovska A, McFarlane SI

At Frisco Quick Care, we take the time to comprehensively evaluate your overall health, discuss potential benefits and risks, and create a personalized weight management plan tailored specifically to you